Symposium 2008
Preparing for a Pharmaceutical Response to Pandemic Influenza
Date of Symposium: October 23-24, 2008
Seton Hall Law School’s Center for Health and Pharmaceutical Law and the SETON HALL LAW REVIEW hosted a symposium on October 23-24, 2008, to examine the legal, ethical, and public policy issues related to developing a pharmaceutical response to an influenza pandemic. Panels explored issues related to the development and approval of vaccines and antiviral drugs, both before and during a pandemic; the allocation of vaccines and antiviral drugs in situations of scarcity; and issues related to international equity.
The symposium was held at Seton Hall Law School’s campus in downtown Newark, New Jersey, which is a short walk from Newark Penn Station and a short taxi ride from Newark International Airport. The symposium was widely publicized to academics, government officials, pharmaceutical industry representatives, and the public, and admission was free. Papers from the symposium were published in a special issue of the SETON HALL LAW REVIEW, which was disseminated free of charge to a broad group of stakeholders, including key government and industry representatives.
The 2008 Seton Hall Law Review Symposium, “Preparing for a Pharmaceutical Response to Pandemic Influenza,” was underwritten by a generous, unrestricted gift from Roche.